Swine Flu Profits: Drug Companies To Reap Billions
Financial Times:
Some of the world's leading pharmaceutical companies are reaping billions of dollars in extra revenue amid global concern about the spread of swine flu.
Analysts expect to see a boost in sales from GlaxoSmithKline, Roche and Sanofi-Aventis when the companies report first-half earnings lifted by government contracts for flu vaccines and antiviral medicines.
Read the whole story: Financial Times



First Posted: 08/20/09 06:12 AM ET Updated: 05/25/11 02:40 PM ET